ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

TidalSense, a Cambridge-based AI respiratory diagnostics company, raised $19 million from Cross-Border Impact Ventures, BGF, Airstream Capital, and Foresight Group. The N-Tidal Diagnose test detects COPD by analyzing a 75-second breath sample. Total funding reaches $40 million. The company plans to expand across Europe and enter the US market.
Tap to vote and see what everyone thinks.
Summary by ByteBrief